Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Minerals, trace elements, Vit. D and bone health

Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis

European Journal of Clinical Nutrition volume 70, pages 995–999 (2016)Cite this article

Subjects

Abstract

Background/Objectives:

The aim of this study was to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) with disability and frequency of relapses in relapsing-remitting multiple sclerosis (MS) patients.

Subjects/Methods:

The study included 184 patients with relapsing-remitting MS who were receiving immune-modulating drugs and no vitamin D supplementation. The concentration of 25(OH)D was measured in February and August 2014. The level of disability was assessed twice according to the Expanded Disability Status Scale (EDSS). The patients were divided into two groups: EDSS 0.0–2 and 2.5–4. The control group comprised 58 age- and sex-matched healthy subjects. The 25(OH)D levels were compared with the occurrence of relapses and the level of disability.

Results:

Mean serum 25(OH)D concentrations were significantly lower in winter in both MS patients and controls. Winter level of 25(OH)D was significantly lower in severe MS cases (EDSS 2.5–4.0) than in mild cases (EDSS 0.0–2.0) (P=0.022), and in the controls (P=0.008), especially in females (r=0.38, P=0.0015). Logistic regression analysis showed the winter serum 25(OH)D was significantly associated with MS (odds ratio 0.925; 95% confidence interval, 0.822–0.970). Serum 25(OH)D levels were significantly lower in MS patients with relapses than in those without relapses both in winter, and in summer.

Conclusions:

Hypovitaminosis D was more prevalent during winter than summer, both in the sample group and the control, especially in female MS patients with higher levels of disability. Low vitamin D levels are associated with a more severe course of disease and an increased number of relapses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Compston A, Coles A . Multiple sclerosis. Lancet 2008; 372: 1502–1517.

    Article  CAS  PubMed  Google Scholar 

  2. Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B . Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011; 82: 1132–1141.

    Article  PubMed  Google Scholar 

  3. Ascherio A, Munger KL, Simon KC . Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9: 599–612.

    Article  PubMed  Google Scholar 

  4. Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76: 540–548.

    Article  CAS  PubMed  Google Scholar 

  5. Sundström P, Salzer J . Vitamin D and multiple sclerosis - from epidemiology to prevention. Acta Neurol Scand 2015; 132: 56–61.

    Article  PubMed  Google Scholar 

  6. Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P . Vitamin D as a protective factor in multiple sclerosis. Neurology 2012; 79: 2140–2145.

    Article  CAS  PubMed  Google Scholar 

  7. Norman AW . From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88: 491S–499S.

    Article  CAS  PubMed  Google Scholar 

  8. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol 2012; 189: 5155–5164.

    Article  CAS  PubMed  Google Scholar 

  9. Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P . The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord Drug Targets 2006; 5: 363–371.

    CAS  PubMed  Google Scholar 

  10. Cantorna MT, Snyder L, Lin YD, Yang L . Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients 2015; 7: 3011–3021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lagishetty V, Liu NQ, Hewison M . Vitamin D metabolism and innate immunity. Mol Cell Endocrinol 2011; 347: 97–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cannell JJ, Hollis BW . Use of vitamin D in clinical practice. Altern Med Rev 2008; 13: 6–20.

    PubMed  Google Scholar 

  13. Holick MF . Vitamin D deficiency. N Engl J Med 2007; 357: 266–281.

    Article  CAS  PubMed  Google Scholar 

  14. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kurtzke JF . On the origin of EDSS. Mult Scler Relat Disord 2015; 4: 95–103.

    Article  PubMed  Google Scholar 

  16. Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010; 68: 193–203.

    CAS  PubMed  Google Scholar 

  17. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R . Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008; 14: 1–5.

    Article  Google Scholar 

  18. Ascherio A, Munger K, Simon C, Kappos L, Polman CH, Freedman MS et al. Serum 25-hydroxyvitamin D concentrations among patients in BENEFIT predicts conversion to multiple sclerosis, MRI lesions, and brain volume loss. Mult Scler 2012; 18 (Suppl. 4), 374–375.

    Google Scholar 

  19. Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol 2012; 72: 234–240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ascherio A, Munger KL, White R, Köchert K, Simon KC, Polman CH et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71: 306–314.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Napiórkowska L, Budlewski T, Jakubas-Kwiatkowska W, Hamzy V, Gozdowski D, Franek E . Prevalence of low serum vitamin D concentration in an urban population of elderly women in Poland. Pol Arch Med Wewn 2009; 119: 699–703.

    PubMed  Google Scholar 

  22. Kubicka K, Pierzchała K . Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study. Neurol Neurochir Pol 2013; 47: 126–130.

    Article  CAS  PubMed  Google Scholar 

  23. Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ . Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 2012; 79: 261–266.

    Article  CAS  PubMed  Google Scholar 

  24. Shahbeigi S, Pakdaman H, Fereshtehnejad SM, Nikravesh E, Mirabi N, Jalilzadeh G . Vitamin D3 concentration correlates with the severity of multiple sclerosis. Int J Prev Med 2013; 4: 585–591.

    PubMed  PubMed Central  Google Scholar 

  25. Mosayebi G, Ghazavi A, Ghasami K, Jand Y, Kokhaei P . Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest 2011; 40: 627–639.

    Article  CAS  PubMed  Google Scholar 

  26. van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania. Australia J Neurol 2007; 254: 581–590.

    CAS  PubMed  Google Scholar 

  27. Yildiz M, Tettenborn B, Putzki N . Vitamin D levels in Swiss multiple sclerosis patients. Swiss Med Wkly 2011; 141: w13192.

    PubMed  Google Scholar 

  28. Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman C et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009; 15: 9–15.

    Article  CAS  PubMed  Google Scholar 

  29. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R et al. A phase I/II dose escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010; 74: 1852–1859.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV . The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. Mult Scler 2013; 19: 1571–1579.

    Article  PubMed  Google Scholar 

  31. Pierrot-Deseilligny C, Rivaud-Péchoux S, Clerson P, de Paz R, Souberbielle JC . Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord 2012; 5: 187–198.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Specialist Hospital, Końskie, Poland

    W Brola, A Góral & M Fudala

  2. Department of Neurology, Holy Spirit Specialist Hospital, Sandomierz, Poland

    P Sobolewski & W Szczuchniak

  3. Paediatric Department, Specialist Hospital, Końskie, and The Faculty of Medicine and Health Science, Institute of Nursing and Obstetrics, Jan Kochanowski University, Kielce, Poland

    W Przybylski

  4. Department of Physical Education, Jerzy Kukuczka Academy of Physical Education, Katowice, Poland

    J Opara

Authors
  1. W Brola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Sobolewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W Szczuchniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Góral
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Fudala
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W Przybylski
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Opara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Brola.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brola, W., Sobolewski, P., Szczuchniak, W. et al. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Eur J Clin Nutr 70, 995–999 (2016). https://doi.org/10.1038/ejcn.2016.51

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2016.51

This article is cited by

Search

Advanced search

Quick links